Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Leuk Lymphoma ; 43(4): 823-6, 2002 Apr.
Article in English | MEDLINE | ID: mdl-12153171

ABSTRACT

The role of bcl 10, a recently cloned apoptosis-associated gene, in diffuse large B-cell lymphoma (DLBL) is unknown. Here we determined the role of bcl 10 gene rearrangement on prognosis. Bcl 10 rearrangement was examined by Southern blot. Bcl 10 rearrangement was detected in 20 of 137 (14.6%) samples of DLBL. The frequency of bcl 10 rearrangement was higher in extranodal (eight of 38 cases, 21%) than in nodal (12 of 99, 12%) DLBL. The survival rate in patients with bcl 10 rearrangement tended to be better than in those with germ-line bcl 10, albeit statistically insignificant probably due to the small population sample. The superior prognosis in patients with bcl 10 rearrangement might be due to bcl 10-induced enhanced apoptosis.


Subject(s)
Gene Rearrangement , Lymphoma, B-Cell/genetics , Lymphoma, Large B-Cell, Diffuse/genetics , Proto-Oncogenes , Adolescent , Adult , Aged , Aged, 80 and over , Child , Chromosomes, Human, Pair 1 , Chromosomes, Human, Pair 14 , Humans , Lymphoma, B-Cell/mortality , Lymphoma, Large B-Cell, Diffuse/mortality , Middle Aged , Prognosis , Survival Rate , Translocation, Genetic
2.
Oncogene ; 20(48): 7029-40, 2001 Oct 25.
Article in English | MEDLINE | ID: mdl-11704827

ABSTRACT

Gammaherpes viruses are often detected in lymphomas arising in immunocompromised patients. We have found that Azidothymidine (AZT) alone induces apoptosis in Epstein Barr Virus (EBV) positive Burkitt's lymphoma (BL) cells but requires interferon alpha (IFN-alpha) to induce apoptosis in Human Herpes Virus Type 8 (HHV-8) positive Primary Effusion Lymphomas (PEL). Our analysis of a series of AIDS lymphomas revealed that IFN-alpha selectively induced very high levels of the Death Receptor (DR) tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in HHV-8 positive PEL lines and primary tumor cells whereas little or no induction was observed in primary EBV+ AIDS lymphomas and EBV-Burkitt's lines. AZT and IFN-alpha mediated apoptosis in PEL was blocked by stable overexpression of dominant negative Fas Associated Death Domain (FADD), decoy receptor 2 (DcR2), soluble TRAIL receptor fusion proteins (DR-4 and DR-5) and thymidine. Trimeric TRAIL (in place of IFN-alpha) similarly synergized with AZT to induce apoptosis in HHV-8 positive PEL cells. This is the first demonstration that IFN-alpha induces functional TRAIL in a malignancy that can be exploited to effect a suicide program. This novel antiviral approach to Primary Effusion lymphomas is targeted and may represent a highly effective and relatively non-toxic therapy.


Subject(s)
Antiviral Agents/pharmacology , Apoptosis/drug effects , Arabidopsis Proteins , Immunologic Factors/pharmacology , Interferon-alpha/pharmacology , Lymphoma, AIDS-Related/therapy , Lymphoma, B-Cell/therapy , Membrane Glycoproteins/physiology , Tumor Necrosis Factor-alpha/physiology , Antimetabolites, Antineoplastic/pharmacology , Antimetabolites, Antineoplastic/therapeutic use , Antiviral Agents/therapeutic use , Apoptosis Regulatory Proteins , Biopolymers , Cysteine Endopeptidases/metabolism , Drug Synergism , Enzyme Activation/drug effects , Epstein-Barr Virus Infections/complications , Etoposide/pharmacology , Fatty Acid Desaturases/biosynthesis , Fatty Acid Desaturases/genetics , Fatty Acid Desaturases/physiology , Gene Expression Regulation, Neoplastic/drug effects , Genes, bcl-2 , HIV Infections/complications , Herpesviridae Infections/complications , Herpesvirus 4, Human/isolation & purification , Herpesvirus 8, Human/isolation & purification , Humans , Immunocompromised Host , Immunologic Factors/therapeutic use , Interferon-alpha/therapeutic use , Lymphoma, AIDS-Related/etiology , Lymphoma, AIDS-Related/immunology , Lymphoma, AIDS-Related/pathology , Lymphoma, B-Cell/etiology , Lymphoma, B-Cell/immunology , Lymphoma, B-Cell/pathology , Membrane Glycoproteins/biosynthesis , Membrane Glycoproteins/chemistry , Membrane Glycoproteins/genetics , Membrane Glycoproteins/pharmacology , Neoplasm Proteins/biosynthesis , Neoplasm Proteins/genetics , Neoplasm Proteins/physiology , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Proto-Oncogene Proteins c-bcl-2/genetics , Receptors, TNF-Related Apoptosis-Inducing Ligand , Receptors, Tumor Necrosis Factor/biosynthesis , Receptors, Tumor Necrosis Factor/genetics , Receptors, Tumor Necrosis Factor/physiology , TNF-Related Apoptosis-Inducing Ligand , Thymidine/pharmacology , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/metabolism , Tumor Necrosis Factor-alpha/biosynthesis , Tumor Necrosis Factor-alpha/chemistry , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/pharmacology
3.
Histopathology ; 39(2): 156-62, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11493332

ABSTRACT

AIMS: Diffuse large B-cell lymphoma (DLBCL), the most common subtype of non-Hodgkin's lymphoma, is clinically and pathologically heterogeneous. The Bcl10 gene was recently isolated from the breakpoint region of t(1;14)(p22;q32) in mucosa-associated lymphoid tissue (MALT) lymphomas, and is considered to be an apoptosis-associated gene. CD10 is considered to be a marker of follicular centre B-cell differentiation. To assess the clinical significance and roles of CD10 and Bcl10 in DLBCL, we analysed 138 cases, using immunohistochemical methods. METHODS AND RESULTS: CD10 expression was limited to the cytoplasm, whereas Bcl10 expression was detected in the cytoplasm and/or nuclei. CD10 expression was detected in 39 of 138 cases (28.2%), cytoplasmic Bcl10 in 68 cases (49.2%), and nuclear Bcl10 in 34 cases (24.6%). Nuclear Bcl10 was detected in 14 of 28 cases (50%) of extranodal DLBCL, but only 20 of 110 cases (18.2%) of nodal DLBCL. Cytoplasmic Bcl10 was detected in 19 of 28 cases (67.8%) of extranodal DLBCL and 49 of 110 cases (44.5%) of nodal DLBCL. CD10 expression closely correlated with improved survival (68% overall survival (OS) vs. 48% OS), but not with site of disease. A high International Prognostic Index (IPI) was considered to be a poor prognostic factor associated with a shorter OS. CD10 expression was detected in 27 of 84 cases (32.1%) with low-risk IPIs, and in 12 of 54 cases (22.2%) with high-risk IPIs. In the low-risk group, cases expressing CD10 carried a better prognosis than CD10- cases (93% OS vs. 71% OS), whereas this was not the case in the high-risk group (25% vs. 20%). CONCLUSIONS: Bcl10 expression was associated with extranodal DLBCL, but not with prognosis. CD10 expression was closely associated with improved survival, but not with risk as predicted by IPI. Overall, our results suggest that CD10 expression may be useful, in combination with clinical parameters, for determining the prognosis of DLBCL.


Subject(s)
Adaptor Proteins, Signal Transducing , Lymphoma, B-Cell/pathology , Lymphoma, Large B-Cell, Diffuse/pathology , Neoplasm Proteins/biosynthesis , Neprilysin/biosynthesis , B-Cell CLL-Lymphoma 10 Protein , Biomarkers, Tumor/analysis , Cell Nucleus/chemistry , Cytoplasm/chemistry , Humans , Immunohistochemistry , Lymphoma, B-Cell/metabolism , Lymphoma, Large B-Cell, Diffuse/metabolism , Prognosis , Survival Analysis
4.
Int J Oncol ; 19(2): 283-9, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11445840

ABSTRACT

Mucosa-associated lymphoid tissue (MALT) lymphomas usually involve extranodal sites, especially the stomach, lung and salivary glands. The Bcl10 gene was recently isolated from the breakpoint region of t(1;14) (p22;q32) in MALT lymphomas, and considered to be an apoptosis-associated gene, and involves a caspase recruitment domain (CARD)-containing protein that activates NF-kappaB. We investigated the role of Bcl10 in MALT lymphoma by analyzing its expression, rearrangement and somatic mutation, by immunostaining, reverse transcriptase-polymerase chain reaction (RT-PCR), Southern blot and PCR in 20 cases of MALT lymphoma. Expression of NF-kappaB was studied by immunostaining. Five cases of reactive lymphadenitis (RLA) were used as the control. Bcl10 rearrangement was detected in 8 of 20 (40%) MALT lymphomas, but in none of RLA. Significant Bcl10 mutation was detected only in 1 case (5%) with MALT, but not in RLA. RT-PCR showed higher density bands of Bcl10 in MALT lymphomas than in RLA. Immunostaining showed a weak Bcl10 expression in the germinal center and very weak expression in the marginal zone B-cells in RLA, which was limited to the cytoplasm. In contrast, Bcl10 was strongly expressed in MALT lymphomas, and was mainly detected in the cytoplasm, as well as in the nuclei. Bcl10 expression did not correlate with Bcl10 mutation and re-arrangements. NF-kappaB was expressed in nuclei of MALT lymphoma cells, but not in RLA. Bcl10 expression in MALT lymphoma correlated closely with NF-kappaB expression. Our results suggest that activation of Bcl10 and NF-kappaB may be important in MALT lymphomagenesis, and that nuclear localization of Bcl10 may be important in the progression of MALT.


Subject(s)
Adaptor Proteins, Signal Transducing , Lymphoma, B-Cell, Marginal Zone/genetics , Neoplasm Proteins/genetics , Adult , Aged , Aged, 80 and over , Amino Acid Substitution , B-Cell CLL-Lymphoma 10 Protein , Blotting, Southern , DNA Mutational Analysis , DNA, Neoplasm/chemistry , DNA, Neoplasm/genetics , Female , Gene Expression Regulation, Neoplastic , Gene Rearrangement , Humans , Immunohistochemistry , Lymphoma, B-Cell, Marginal Zone/metabolism , Lymphoma, B-Cell, Marginal Zone/pathology , Male , Middle Aged , Mutation , NF-kappa B/analysis , NF-kappa B/genetics , Neoplasm Proteins/analysis , Point Mutation , Polymorphism, Single-Stranded Conformational , RNA, Neoplasm/genetics , RNA, Neoplasm/metabolism , Reverse Transcriptase Polymerase Chain Reaction
5.
Cancer Res ; 59(21): 5514-20, 1999 Nov 01.
Article in English | MEDLINE | ID: mdl-10554028

ABSTRACT

Lymphoproliferative diseases that occur in immunocompromised patients are frequently associated with herpesviruses. These patients often fare poorly after treatment with conventional chemotherapy. We reported previously that patients with AIDS-related Burkitt's lymphoma (BL) responded to parenteral azidothymidine (AZT) and IFN-alpha. We found that EBV-positive lymphoma cells derived from these patients cultured with AZT express CD95 and undergo apoptosis. AZT-mediated apoptosis was caspase dependent and occurred despite Fas receptor blockade. In contrast, EBV-negative lymphomas were resistant to AZT-induced apoptosis, as were EBV-positive lymphomas that expressed high levels of bcl-2. Primary effusion lymphoma (PEL) cell lines infected with human herpesvirus type 8 required IFN-alpha to potentiate AZT-induced apoptosis. IFN-alpha did not up-regulate CD95 in BL or PEL but did induce expression of the death receptor ligand, CD95 ligand. AZT-sensitive lymphomas also accumulated significantly higher intracellular AZT monophosphate than did resistant lymphomas. Our data demonstrated distinct apoptotic responses to AZT and IFN-alpha in herpesvirus-associated lymphomas. EBV-positive BL cells that expressed low BCL-2 levels were sensitive to AZT alone; PEL cells required the addition of IFN-alpha to enhance apoptosis, and EBV-negative lymphomas were insensitive to both agents. AZT-sensitive BL cells transfected with BCL-2 became resistant. Susceptibility to antivirus-mediated apoptosis may be exploited to improve the therapy of certain herpesvirus-associated lymphomas.


Subject(s)
Apoptosis , Herpesvirus 8, Human/metabolism , Interferon-alpha/pharmacology , Lymphoma/metabolism , Zidovudine/pharmacology , Burkitt Lymphoma/metabolism , Caspases/metabolism , Dose-Response Relationship, Drug , Flow Cytometry , Herpesvirus 4, Human/metabolism , Humans , Lymphoma, AIDS-Related/pathology , Lymphoma, Non-Hodgkin/pathology , Phosphorylation , Proto-Oncogene Proteins c-bcl-2/metabolism , Time Factors , Transfection , Tumor Cells, Cultured , Up-Regulation , fas Receptor/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...